Health Care: Drugs

Arena Pharmaceuticals Inc (ARNA: NASDAQ)

$4.63 -0.14 | -2.94%
07/31/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 4.77
52 Week High 7.97
52 Week Low 4.05
Avg. Daily Vol. (Mil) 5.29
Beta (3 year) -2.51
Share Related Items
Mkt Cap (Mil) 1,047.73
Shares Out (Mil) 219.65
Float (Mil) 188.35
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.90
Current Ratio 4.10
LT Debt/ Equity 0.56
Total Debt / Equity 0.57
Valuation Ratios
Price Earnings n.a.
Price/Sales 12.21
Price/Book 8.31
Price/Cash Flow -60.40
Per Share Data
Earnings -0.12
Sales 0.39
Book Value 0.57
Cash Flow -0.08
Business Summary
Arena Pharmaceuticals, Inc., is a biopharmaceutical company engaged on discovering, developing and commercializing drugs that target G protein-coupled receptors to address unmet medical needs.
General Information
6154 Nancy Ridge Drive
San Diego, CA 92121
www.arenapharm.com
Industry : Drugs
Sector: Health Care
Employees: 310
CEO: Jack Lief
Short Interest
Current Month (Mil) 41.04
Previous Month (Mil) 41.74
Short Interest Ratio (Days) 7.50
Management Effectiveness
Return on Equity n.a.
Return on Assets -7.00
Return on Investments -13.20
Profitability
Gross Margin 93.70
EBIT Margin -31.70
Profit Margin -30.10

Portfolios with ARNA

Latest ARNA Headlines from TheStreet

More Financial News for ARNA

Press Releases for ARNA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter